全文获取类型
收费全文 | 2663篇 |
免费 | 194篇 |
国内免费 | 9篇 |
专业分类
耳鼻咽喉 | 20篇 |
儿科学 | 56篇 |
妇产科学 | 22篇 |
基础医学 | 446篇 |
口腔科学 | 20篇 |
临床医学 | 318篇 |
内科学 | 497篇 |
皮肤病学 | 18篇 |
神经病学 | 423篇 |
特种医学 | 118篇 |
外科学 | 344篇 |
综合类 | 3篇 |
一般理论 | 5篇 |
预防医学 | 136篇 |
眼科学 | 66篇 |
药学 | 202篇 |
中国医学 | 5篇 |
肿瘤学 | 167篇 |
出版年
2024年 | 3篇 |
2023年 | 18篇 |
2022年 | 41篇 |
2021年 | 109篇 |
2020年 | 45篇 |
2019年 | 93篇 |
2018年 | 101篇 |
2017年 | 58篇 |
2016年 | 88篇 |
2015年 | 105篇 |
2014年 | 119篇 |
2013年 | 156篇 |
2012年 | 238篇 |
2011年 | 253篇 |
2010年 | 141篇 |
2009年 | 107篇 |
2008年 | 173篇 |
2007年 | 179篇 |
2006年 | 166篇 |
2005年 | 150篇 |
2004年 | 135篇 |
2003年 | 120篇 |
2002年 | 82篇 |
2001年 | 18篇 |
2000年 | 9篇 |
1999年 | 14篇 |
1998年 | 27篇 |
1997年 | 20篇 |
1996年 | 16篇 |
1995年 | 14篇 |
1994年 | 10篇 |
1993年 | 14篇 |
1992年 | 4篇 |
1991年 | 5篇 |
1990年 | 6篇 |
1989年 | 4篇 |
1988年 | 1篇 |
1987年 | 2篇 |
1986年 | 1篇 |
1985年 | 3篇 |
1984年 | 3篇 |
1983年 | 2篇 |
1982年 | 3篇 |
1981年 | 2篇 |
1979年 | 1篇 |
1978年 | 1篇 |
1973年 | 1篇 |
1933年 | 3篇 |
1931年 | 2篇 |
排序方式: 共有2866条查询结果,搜索用时 15 毫秒
31.
Xavier Leleu Ga?lle Le Friec Thierry Facon Laurence Amiot Renée Fauchet Bernadette Hennache Valérie Coiteux Ibrahim Yakoub-Agha Sylvain Dubucquoi Hervé Avet-Loiseau Claire Mathiot Régis Bataille Jean-Yves Mary 《Clinical cancer research》2005,11(20):7297-7303
Serum beta2-microglobulin, the light chain of the HLA class I molecular complex, remains one of the best survival prognostic factors in multiple myeloma, but other HLA class I molecules might be of interest in monoclonal gammopathies. In this study, we evaluate total soluble HLA class I (HLA-Is) and soluble HLA-G (HLA-Gs) in 103 patients with newly diagnosed multiple myeloma, 30 patients with monoclonal gammopathy of undetermined significance (MGUS), and 30 healthy subjects, studying their prognostic value in multiple myeloma. In multiple myeloma patients, HLA-Is and HLA-Gs median values were 0.8 microg/mL and 28 ng/mL, respectively. Median HLA-Is concentration was higher in stage II and III multiple myeloma patients than in stage I multiple myeloma, MGUS, and control patients. Median HLA-Gs was significantly lower in healthy controls than in MGUS and multiple myeloma patients. A high level of HLA-Is (> or =2.1 microg/mL) was predictive of short survival (P = 0.017). For each given level of beta2-microglobulin, the relative risk of death was higher for patients with HLA-Is > or = 2.1 microg/mL than in patients with a lower level (P = 0.047). HLA-Gs, a marker of monoclonal gammopathy, was of no prognostic value, but the addition of HLA-Is to beta2-microglobulin produced an efficient prognostic score (P < 0.0001). HLA-Is is a new marker of multiple myeloma tumor load and provides additional survival prognostic information to beta2-microglobulin. 相似文献
32.
33.
34.
35.
Laetitia Souchet-Compain Stéphanie Nguyen Sylvain Choquet Véronique Leblond 《Clinical Lymphoma, Myeloma & Leukemia》2013,13(2):227-230
Waldenström macroglobulinemia is a rare chronic lymphoproliferative disorder. Treatments are currently reserved for symptomatic patients and usually consist of nucleoside analogues (NAs), alkylating agents, bortezomib, and monoclonal antibodies, alone or in combination. Fludarabine and 2-chlorodeoxyadenosine (2-CdA) have been studied in first-line treatment of Waldenström macroglobulinemia (WM) since the end of the 1990s. In monotherapy, response rates vary between 36% and 94%. In a phase III trial, fludarabine in monotherapy was more efficient than chlorambucil for progression-free survival (PFS) (37.8 vs. 27.1 months), duration of response (DOR) (38.5 vs. 21.3 months) and overall survival (OS) (median not reached vs. 69.8 months), but the overall response rate (ORR) was similar (45.6% and 35.9%). NAs have been studied in combination with rituximab and/or alkylating agents for increasing the quality and duration of the response. Hematologic toxicities are a major concern, limiting the indication for NAs in first-line treatment to patients who are not candidates for autologous stem cell transplantation, those in need of rapid control of the disease, or those with poor prognostic factors. 相似文献
36.
In this research, bibliotherapy combined with a positive reinforcement procedure was applied to the treatment of premature ejaculation. The results indicate that it is possible to obtain significant improvement in ejaculatory latency by using only a self-administered treatment. Moreover, this study indicates that this improvement is identical to the one obtained when therapists conduct the treatment. Although more subjects treated by bibliotherapy quit the treatment, bibliotherapy was very useful 相似文献
37.
38.
39.
40.